NATALIE CARVALHO

Publications

• Comparing Health Gains, Costs and Cost-Effectiveness of 100s of Interventions in Australia and New Zealand: An Online Interactive League Table
• Prevention of bacterial complications of scabies using mass drug administration: A population-based, before-after trial in Fiji, 2018–2020
• Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysis.
• Characterizing the epidemiological transition in Mexico: National and subnational burden of diseases, injuries, and risk factors
• Expenditures and prices of antihyperglycemic medications in the United States: 2002-2013
• Alternative strategies to reduce maternal mortality in India: A cost-effectiveness analysis
• Erratum: Characterizing the epidemiological transition in Mexico: National and subnational burden of diseases, injuries, and risk factors(PLoS Med(2008), 5, 6, (e125), 10.1371/journal.pmed.0050125).
• Proportional multistate lifetable modelling of preventive interventions: concepts, code and worked examples.
• The probability of the 6-week lockdown in Victoria (commencing 9 July 2020) achieving elimination of community transmission of SARS-CoV-2.
• Cost-effectiveness of inhaled oxytocin for prevention of postpartum haemorrhage: a modelling study applied to two high burden settings.
• Impact of Indonesia's national health insurance scheme on inequality in access to maternal health services: A propensity score matched analysis.
• Hospital admissions for skin and soft tissue infections in a population with endemic scabies: A prospective study in Fiji, 2018-2019.
• Impact of comorbid conditions on health care expenditure and work-related outcomes in patients with rheumatoid arthritis.
• Comparing health gains, costs and cost-effectiveness of 100s of interventions in Australia and New Zealand: an online interactive league table
• Integrated Quantification of the Health and Economic Impacts of Differing Strategies to Control the COVID-19 Pandemic
• Prospective surveillance for invasive Staphylococcus aureus and group A Streptococcus infections in a setting with high community burden of scabies and impetigo
• Association between 24-hour movement behaviors and health-related quality of life in children
• Determining the optimal COVID-19 policy response using agent-based modelling linked to health and cost modelling: Case study for Victoria, Australia
• Direct and indirect costs of acute diarrhea in children under five years of age in Indonesia: Health facilities and community survey
• Impact of tax and tobacco-free generation on health-adjusted life years in the Solomon Islands: A multistate life table simulation
• Azithromycin or doxycycline for asymptomatic rectal chlamydia trachomatis
• Prospective surveillance of primary healthcare presentations for scabies and bacterial skin infections in Fiji, 2018-2019
• Priority setting for health interventions in Mexico's System of Social Protection in Health,Definición de prioridades para las intervenciones de salud en el Sistema de Protección Social en Salud de México
• VITALITY trial: Protocol for a randomised controlled trial to establish the role of postnatal Vitamin D supplementation in infant immune health
• National and sub-national analysis of the health benefits and cost-effectiveness of strategies to reduce maternal mortality in Afghanistan
• Priority setting for health interventions in Mexico's System of Social Protection in Health
• More evidence on the impact of India's conditional cash transfer program, Janani Suraksha Yojana: Quasi-experimental evaluation of the effects on childhood immunization and other reproductive and child health outcomes
• Feasibility of a Health-Utility Approach to Quantifying Noneconomic Losses from Personal Injury
• The Impact of India’s Janani Suraksha Yojana Conditional Cash Transfer Programme: A Replication Study
• Cost-effectiveness of universal iron supplementation and iron-containing micronutrient powders for anemia among young children in rural Bangladesh: analysis of a randomized, placebo-controlled trial
• Costs of mass drug administration for scabies in Fiji
• Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework
• Accounting for equity considerations in cost-effectiveness analysis: a systematic review of rotavirus vaccine in low- and middle-income countries
• The impact of Medicare part D on income-related inequality in pharmaceutical expenditure
• The probability of the 6‐week lockdown in Victoria (commencing 9 July 2020) achieving elimination of community transmission of SARS‐CoV‐2
• Potential Cost-Effectiveness of Maternal Influenza Immunisation in Low-Income Countries: An Explorative Modelling Study and Value of Information Analysis to Guide Future Clinical Research
• Inequitable Distribution of Global Economic Benefits from Pneumococcal Conjugate Vaccination
• Evaluation of rotavirus, pneumococcal conjugate and human papillomavirus vaccination in four Pacific island countries: A cost-effectiveness modelling study
• Do the Age of Children and Parental Status Matter in Valuing the Child Health Utility 9D (CHU9D)?